Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 89,415

Document Document Title
WO/2016/055971A3
Provided herein are novel methods, systems and processes of mapping and assembling sequence reads. Also provided herein are methods, systems and processes of identifying the presence or absence of a genetic variation in a genome of a sub...  
WO/2016/055879A1
The present invention refers to a process designed to increase the production of plant growth-promoting microorganisms of the Bacillus genus, using a culture medium poor in nutrients and with specific environmental conditions, allowing t...  
WO/2016/050861A1
The present invention relates to methods for cultivating a nitrile hydratase producing microorganism, compositions for cultivating a nitrile hydratase producing microorganism, and use of compositions comprising a saccharide and an organi...  
WO/2016/051983A1
The present invention addresses the problem of providing a cell culture medium, particularly a serum-free cell culture medium, in which the cell proliferation efficiency can be improved without requiring the use of feeder cells. Accordin...  
WO/2016/050654A1
Suggested is a culture of Amycolatopsis sp. ATCC 39116 - mutant F33 or mutant F86 which converts ferulic acid into vanillin.  
WO/2016/049918A1
Biomarkers and methods for predicting the risk of a disease related to microbes are provided, in particular coronary artery disease (CAD) or related heart diseases.  
WO/2016/050111A1
Biomarkers for rheumatoid arthritis (RA) are described. RA-associated metagenomic linkage groups (MLGs) have been identified and validated in gut and oral microbiotas. These MLGs are used in systems, methods and products for identifying ...  
WO/2016/053309A1
The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile st...  
WO/2016/053397A3
This invention relates to metabolically engineered microorganisms, such as bacterial and or fungal strains, and bioprocesses utilizing such strains. These strains enable the dynamic control of metabolic pathways, which can be used to opt...  
WO/2016/049826A1
Use of Bacteroides uniformis in the preparation of a formulation for treatment and/or prevention of coronary artery disease, or for decreasing the level of blood glucose or lipids, or for ameliorating coronary atherosclerotic lesions. An...  
WO/2016/049927A1
Biomarkers and methods for predicting the risk of a disease related to microbes, in particular obesity or related diseases, are provided.  
WO/2016/049937A1
Biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA), are provided.  
WO/2016/049761A1
36849-014 65 7633800.2 ABSTRACT There are provided efficient and cost-effective methods for purifying biomolecules in solution phase using stimuli-responsive protein-polymer conjugates. The protein- polymer conjugates comprise a target b...  
WO/2016/049932A1
The present invention provides biomarkers and methods for predicting the risk of a disease related to microbes, in particular obesity or related diseases.  
WO/2016/053397A2
This invention relates to metabolically engineered microorganisms, such as bacterial and or fungal strains, and bioprocesses utilizing such strains. These strains enable the dynamic control of metabolic pathways, which can be used to opt...  
WO/2016/049879A1
Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an anima...  
WO/2016/053648A1
A method for treating a low value carbon source to produce biologically labile carbon, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low value...  
WO/2016/050110A1
Biomarkers and methods for predicting risk of a disease in particular RA are provided. Sequences of DNA are obtained. The DNA may be extracted from a sample that is collected from a subject. A relative abundance of a biomarker is then ca...  
WO/2016/053131A1
The invention relates to the microbiology industry, microbiology and biotechnology, and specifically to the production of physiologically-active compounds, and concerns the production of the protein bacteriorhodopsin by means of micro...  
WO/2016/049936A1
The present invention provides biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA).  
WO/2016/049827A1
The use of Bacteroides bacterial strains in the preparation of a formulation for the treatment and/or prevention of coronary artery disease, or for decreasing the level of blood glucose or lipids, or for ameliorating coronary atheroscler...  
WO/2016/049930A1
Biomarkers and methods for predicting the risk of a disease related to microbiota, in particular rheumatoid arthritis (RA), are provided.  
WO/2016/052174A1
The purpose of the present invention is to provide: an algae water concentration system for concentrating algae water in a culture pond into algae water containing desired sizes of algae with a single configuration, at low cost and with ...  
WO/2016/049883A1
Provided are uses of Bacteroides in preparation of a medicament. The medicament is for use in treatment or prevention of obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an anima...  
WO/2016/053649A1
A method for treating a low value carbon source to produce biologically labile carbon, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low value...  
WO/2016/051358A1
The present disclosure relates to thermo-stable/heat stable strain(s) of micro-organisms, obtaining such thermo-stable strains and incorporating them into food products. These strains are able to survive high temperatures for longer peri...  
WO/2016/047907A1
The present invention relates to a composition, containing tyndallized lactobacillus dead cells as an active ingredient, for skin moisturizing or wrinkle improvement. The effect of the tyndallized lactobacillus dead cells on skin moistur...  
WO/2016/046321A1
The present invention relates to an attenuated mutant of Toxoplasma gondii for use in the prevention or the treatment of cancer or of infectious diseases in a subject in need thereof wherein the attenuated mutant 1) expresses one or more...  
WO/2016/048828A1
A method for synthesizing isoamyl alcohol and/or isobutanol from a low value carbon source, comprising the steps of oxidizing the low value carbon source with at least one oxidizing agent to produce a modified, partially solubilized low ...  
WO/2016/044956A1
An Enterobacter species isolated from finger millet, characterized by 16S rRNA gene analysis and the identification of genes that prevent or inhibit the growth of fungal plant pathogens, is disclosed for use with agricultural plants.  
WO/2016/044950A1
Disclosed are new approaches to detecting adenosine deaminase (ADA) deficiency. There is provided a method of determining ADA activity, comprising: dividing a sample obtained from blood into two portions, adding an ADA inhibitor to one p...  
WO/2016/046137A1
The present invention relates in particular to a method for the expression of a protein of interest by a bacterium, notable in that it comprises the culturing of a bacterium temporarily or continuously expressing an Hsp protein, in that ...  
WO/2016/048046A1
The present invention relates to a method for increasing mannose phosphorylation by using YlMpo1 overexpression and, more specifically, to a method for preparing a bi-mannosylphosphorylated glycan-added protein by overexpressing YlMpo1 p...  
WO/2016/047656A1
It is tried to produce an antibody capable of neutralizing the activity of a substance having an activity alternative to the function of FVIII, for the purpose of using the antibody in a method for measuring the reactivity of FVIII in th...  
WO/2016/049574A3
Phagotrophic algae are used in connection with aerobic or anaerobic digestion of solids, especially waste activated sludge (WAS), to more efficiently digest solids and to meet, over a shorter period of time, volatile solids standards and...  
WO/2016/045569A1
Processes for producing ethanol comprise saccharifying cellulosic material with a cellulolytic enzyme composition and fermenting the saccharified cellulosic material with a fermenting microorganism to produce ethanol. The fermenting orga...  
WO/2016/047368A1
A cell dissociation device is equipped with: a holding means 11 for holding a container D that carries cells C on a flat bottom surface thereof; an ultrasonic wave ejection means 121 which is arranged apart from the container D held by t...  
WO/2016/047444A1
The present invention pertains to: a cell separation material comprising fibers having an average fiber diameter of 1.0-50 µm, air permeability of 10-400 cc/cm2/sec, and a compression energy WC of no more than 3.5 J/m2; a cell separatio...  
WO/2016/047722A1
A novel multispecific antigen-binding molecule, which comprises a domain containing an antibody variable region having an activity of binding to glypican 3 and a domain containing an antibody variable region having an activity to bind to...  
WO/2016/046428A1
The invention relates to the use of chitosan for increasing the formation of appressoria in Pochonia chlamydosporia and/or increasing the pathogenicity of Pochonia chlamydosporia on eggs of nematodes. The invention also relates to the us...  
WO/2016/047786A1
A solubilization device (100) solubilizes organic waste material to be sent to a methane fermentation tank. A first storage tank (10) stores the organic waste material before being sent to the methane fermentation tank. In solubilization...  
WO/2016/044773A1
The present invention is drawn to conjugates and vaccine compositions comprising a Pseudomonas flagellin or an antigenic fragment or derivative thereof linked to one or more Klebsiella surface polysaccharide antigens, such as Klebsiella ...  
WO/2016/044510A1
The present disclosure describes a method of treating a sample comprising cells with a process of partial lysing. Cells are exposed to a process such as bead beating that lyses some cells in the mixture. The process generates a resultant...  
WO/2016/042160A1
The present invention relates to a new strain of Clostridium acetobutylicum modified to be unable to produce hydrogen and its use for the continuous production of bulk chemicals such as lactate, 1,3 -propanediol, ethanol, butanol, isobut...  
WO/2016/044001A1
A method for producing astaxanthin incorporates a method for producing astaxanthin-rich algae cells and a method for extracting astaxanthin therefrom. An initial feedstock comprises healthy algae, water, and nutrients. During a growth ph...  
WO/2016/044723A1
A method of reducing undesirable microorganism concentration, the method comprises (a) introducing a quantity of fermentable carbohydrate to an aqueous system, (b) introducing a quantity of desirable microorganism to the aqueous system, ...  
WO/2016/043383A1
The present invention relates to a method for synthesizing formic acid, the method being characterized in that carbon dioxide is electrochemically reduced using an electron source, an electron transporter, and methylotrophic bacteria tha...  
WO/2016/044336A1
This disclosure describes modified photosynthetic microorganisms, including Cyanobacteria, that have a reduced amount of a light harvesting protein (LHP) polypeptide and contain one or more introduced or overexpressed polynucleotides enc...  
WO/2016/042267A1
The invention concerns a method for producing a compound of interest of the sterol biosynthesis pathway in a eukaryotic organism or a derivative of a compound of the sterol biosynthesis pathway in said eukaryotic organism, in particular ...  
WO/2016/044456A1
Disclosed is an invention that relates to the formation of microsclerotial propagules by mycoparasitic fungi and the use of those microsclerotia for plant disease control. Representative microscleroita propagules formed are from fugal sp...  

Matches 151 - 200 out of 89,415